(EMXC) iShares MSCI Emerging - Ratings and Ratios
Stocks, Futures, Options, Swaps, Cash
Dividends
| Dividend Yield | 2.39% |
| Yield on Cost 5y | 3.37% |
| Yield CAGR 5y | 15.91% |
| Payout Consistency | 90.9% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 15.0% |
| Value at Risk 5%th | 25.3% |
| Relative Tail Risk | 2.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.21 |
| Alpha | 14.81 |
| CAGR/Max DD | 0.88 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.461 |
| Beta | 0.684 |
| Beta Downside | 0.722 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.12% |
| Mean DD | 3.82% |
| Median DD | 2.97% |
Description: EMXC iShares MSCI Emerging October 30, 2025
The iShares MSCI Emerging Markets ex China ETF (NASDAQ: EMXC) seeks to track a free-float-adjusted, market-cap weighted index that covers large- and mid-cap stocks in 23 of the 24 emerging-market economies, explicitly excluding China. The fund commits at least 80 % of its assets to the index’s component securities (or securities with substantially identical economic characteristics) and may allocate up to the remaining 20 % to futures, options, swaps, cash, and cash equivalents for liquidity or tactical purposes.
Key quantitative points (as of the latest public filings) include an expense ratio of roughly 0.20 %, total assets under management of about $3 billion, and an annualized distribution yield near 2.5 %. The ETF’s sector tilt is heavily weighted toward information technology (≈30 % of assets, driven by companies such as Taiwan Semiconductor) and financials (≈20 %). Economic drivers that tend to move the portfolio’s performance are commodity price cycles (affecting resource-rich nations like Brazil and Chile), domestic consumption growth in India, and the monetary-policy stance of major non-China emerging economies.
If you want a deeper, data-rich view of EMXC’s risk-adjusted returns and how its factor exposures compare across the emerging-market space, the ValueRay platform provides a free, interactive dashboard that can help you surface those insights.
What is the price of EMXC shares?
Over the past week, the price has changed by -0.49%, over one month by +0.87%, over three months by +6.86% and over the past year by +25.58%.
Is EMXC a buy, sell or hold?
What are the forecasts/targets for the EMXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 81.1 | 13.4% |
EMXC Fundamental Data Overview December 05, 2025
Beta = 0.92
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 13.19b USD (13.19b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 13.19b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 13.19b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.54% (E(13.19b)/V(13.19b) * Re(8.54%) + (debt-free company))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for EMXC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle